Biotech & Medtech
Biotech & Medtech news — Wednesday 21 October 2026
30 stories from 5 sources, every one in English. Each links to its publisher.
-
Judi Health Launches Medicare Part D Plan for Employers
MedCity News
Judi Health launched Judi Rx Retire, an employer-sponsored Medicare Part D plan designed to improve pricing transparency and streamline benefits administration. The post Judi Health Launches Medicare Part D Plan for Employers appeared…
-
STAT+: CMS extends fraud crackdown to New York’s adult day care program
STAT News
Just one week after being granted the authority to kick providers off of federal health care programs, U.S. health officials are using it on adult day care centers in New York City they say are committing fraud. Officials with the Centers…
-
STAT+: Another diabetes association leader is out while review continues
STAT News
Just over six weeks after the American Diabetes Association said its review of an incident at its New Orleans meeting in June would need more time, one of its top leaders is out. Rita Kalyani, chief scientific and medical officer, “is no…
-
GSK Wins FDA Nod for Novel Hepatitis B Drug Offering a Potential Functional Cure
MedCity News
GSK’s Hibsago brings a new mechanism of action to chronic hepatitis B, targeting the genetic instructions the virus uses to make copies of itself and viral proteins. This drug was licensed from antisense oligonucleotide specialist Ionis…
-
STAT+: What’s the deal with Isomorphic Labs?
STAT News
This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. Some of the best quotes from last week’s STAT Summit…
-
AMA Calls for Risk-Based GenAI Oversight to Protect Patients and Support Responsible Innovation
MedCity News
As generative AI moves toward performing increasingly consequential clinical functions, the American Medical Association (AMA) is urging the U.S. Food and Drug Administration to address a foundational question: Who is responsible for…
-
GSK, Ionis win US approval for first-of-its-kind hepatitis B drug
BioPharma Dive
Hibsago is viewed as a potential “functional cure” for chronic infections and an important part of the British drugmaker’s goal of reaching £40 billion in annual revenue by 2031.
-
Roivant, continuing ascent, claims another victory for rare disease drug
BioPharma Dive
Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also be a “best-in-disease” medicine for an inflammatory eye condition, one analyst said.
-
STAT+: GSK picks up hep B drug approval
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Last spring, my colleague received an intriguing email from Mark Cuban. From there, a story was born…
-
Arcus kidney cancer data impresses analysts; TriGemX inks a SPAC deal
BioPharma Dive
New follow-up results suggest Arcus’ drug might be superior to a marketed Merck medicine. Elsewhere, Eli Lilly and AstraZeneca forged new partnerships.
-
Your Product Works — So Why Does It Still Fail in the Real World?
MedCity News
A patient’s automated risk score was reassuringly green. Pulling from a sparse medical record and infrequent acute visits, the model flagged him as low risk and routed him to the default, low-touch outpatient pathway — so why was the…
-
STAT+: Pharmalittle: We’re reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and more
STAT News
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While…
-
STAT+: Roivant says closely watched immune drug succeeded in new eye disease
STAT News
Roivant and its spinout Priovant said Wednesday that their immune-modifying pill Lisraya was more effective than placebo in treating the inflammatory eye disease non-infectious uveitis. The results, from two Phase 3 trials spanning 371…
-
Nigeria identifies travel-related Ebola case
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Good morning. I’m seeing “You Can See Everything” tonight, so I haven’t read Matt Herper’s review yet. But you should! If…
-
A counterintuitive way to build trust in measles vaccines and public health
STAT News
With more than 4,400 measles cases in the United States this year, double the number in 2025, public health authorities are desperate to persuade more people to take the virus seriously. But current attempts to drive home that message are…
-
STAT+: Mark Cuban wants to crack open the market for rare disease treatments
STAT News
Billionaire Mark Cuban has spent the last five years trying to make generic drugs like chemotherapy and antifungal ointment cheaper for Americans. But earlier this year, a very different type of medicine began arriving at his Dallas…
-
Opinion: Replication is necessary even if scientists do everything right
STAT News
When National Institutes of Health Director Jay Bhattacharya started laying out his plans in 2025, he emphasized replication as part of the gold standard for science. In March, he launched the $850,000 Replication Prize for replicating…
-
STAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved
STAT News
Presidential sessions at top cancer meetings typically feature practice-changing clinical trials, detailed in front of thousands of global experts packed into rooms so cavernous they merit their own ZIP codes. But last year, at the most…
-
Opinion: How knocking on doors can help beat measles — again
STAT News
On Oct. 12, Pennsylvania confirmed its sixth measles-associated death this year. The state’s outbreak has spread to dozens of counties, sickened over 1,200 people , and put 176 in the hospital. More than 4,400 confirmed cases of measles…
-
Reinforced Linear Genetic Programming
arXiv cs.NE (Neural／Bio)
arXiv:2601.09736v2 Announce Type: replace Abstract: Linear Genetic Programming (LGP) is a powerful technique that allows for a variety of problems to be solved using a linear representation of programs. However, there still exists some…
-
Migrate Computation, Not Data: Fault Recovery in Neuromorphic Many-Core Systems
arXiv cs.NE (Neural／Bio)
arXiv:2610.26985v1 Announce Type: new Abstract: As neuromorphic systems scale to thousands of near-memory cores, aging-induced permanent faults in neuron-update datapaths become an important obstacle to long-term deployment. Existing…
-
Multi-Objective Evolutionary Semi-Supervised Learning for Resource-Aware Smart City Classification
arXiv cs.NE (Neural／Bio)
arXiv:2610.27703v1 Announce Type: cross Abstract: Smart-city applications often combine scarce labeled data with abundant unlabeled observations. Semi-supervised learning (SSL) exploits both labeled and unlabeled data to improve…
-
Taskonomy: Disentangling Task Transfer Learning
arXiv cs.NE (Neural／Bio)
arXiv:1804.08328v2 Announce Type: replace-cross Abstract: Do visual tasks have a relationship, or are they unrelated? For instance, could having surface normals simplify estimating the depth of an image? Intuition answers these questions…
-
One-shot learning of paired association navigation with biologically plausible schemas
arXiv cs.NE (Neural／Bio)
arXiv:2106.03580v5 Announce Type: replace Abstract: After learning a multiple paired-association (MPA) navigation task, rodents can rapidly learn new cue-location associations after a single exposure, a phenomenon proposed to be…
-
Compute-Optimal Scaling Laws for Spiking Language Models
arXiv cs.NE (Neural／Bio)
arXiv:2610.15146v2 Announce Type: replace-cross Abstract: Spiking neural networks target energy-efficient language modeling through sparse, binary activations, but the efficiency-accuracy tradeoff of spiking language models is…
-
Predator-Prey Model: Driven Hunt for Accelerated Grokking
arXiv cs.NE (Neural／Bio)
arXiv:2509.10562v2 Announce Type: replace Abstract: A machine learning method is proposed using two agents (representing two coupled replicas of the model parameters) that simulate the biological behavior of a predator and a prey. In this…
-
Online Continual Learning on Intel Loihi 2 via a Co-designed Spiking Neural Network
arXiv cs.NE (Neural／Bio)
arXiv:2511.01553v3 Announce Type: replace-cross Abstract: Edge AI must adapt to new classes and shifting data within a tight power budget, but online continual learning (learning from each sample before the next arrives) is where…
-
Differential Functionalism: Jacobians Shape the Structure of Phenomenal Experience
arXiv cs.NE (Neural／Bio)
arXiv:2609.09306v3 Announce Type: replace-cross Abstract: This paper investigates the hypothesis that the first-order structure of physical interactions (Jacobians) shapes the structure of phenomenal experience. Two measures of Jacobian…
-
Recordanelles for transcriptome-wide single-cell RNA recording in human cells
Nature Biotechnology
Nature Biotechnology, Published online: 21 October 2026; doi:10.1038/s41587-026-03327-6 Recordanelles continuously and unbiasedly record the transcriptome throughout time in living mammalian cells.
-
Deep dynamical models of single-cell multiomic velocities predict loss-of-function and rescue perturbations in B cells
Nature Biotechnology
Nature Biotechnology, Published online: 21 October 2026; doi:10.1038/s41587-026-03348-1 DynaVelo integrates single-cell omics data to infer cell state dynamics and regulatory interactions.